Bieber Brian, Qian Jiaqi, Anand Shuchi, Yan Yucheng, Chen Nan, Wang Mia, Wang Mei, Zuo Li, Hou Fan Fan, Pisoni Ronald L, Robinson Bruce M, Ramirez Sylvia P B
Arbor Research Collaborative for Health, Ann Arbor, MI, USA.
Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Nephrol Dial Transplant. 2014 Sep;29(9):1770-7. doi: 10.1093/ndt/gft472. Epub 2013 Dec 8.
Renal replacement therapy is rapidly expanding in China, and two-times weekly dialysis is common, but detailed data on practice patterns are currently limited. Using cross-sectional data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we describe the hemodialysis practice in China compared with other DOPPS countries, examining demographic, social and clinical characteristics of patients on two-times weekly dialysis.
The DOPPS protocol was implemented in 2011 among a cross-section of 1379 patients in 45 facilities in Beijing, Guangzhou and Shanghai. Data from China were compared with a cross section of 11 054 patients from the core DOPPS countries (collected 2009-11). Among China DOPPS patients, logistic and linear regression were used to describe the association of dialysis frequency with patient and treatment characteristics and quality of life.
A total of 26% of the patients in China were dialyzing two times weekly, compared with < 5% in other DOPPS regions. Standardized Kt/V was lowest in China (2.01) compared with other regions (2.12-2.27). Female sex, shorter dialysis vintage, lower socioeconomic status, less health insurance coverage, and lack of diabetes and hypertension were associated with dialyzing two times weekly (versus three times weekly). Patients dialyzing two times per week had longer treatment times and lower standardized Kt/V, but similar quality of life scores.
Two-times weekly dialysis is common in China, particularly among patients, who started dialysis more recently, have a lower comorbidity burden and have financial constraints. Quality of life scores do not differ between the two-times and three-times weekly groups. The effect on clinical outcomes merits further study.
肾脏替代治疗在中国迅速普及,每周两次透析很常见,但目前关于实践模式的详细数据有限。利用中国透析结局和实践模式研究(DOPPS)的横断面数据,我们描述了中国血液透析的实践情况,并与其他DOPPS国家进行比较,研究每周两次透析患者的人口统计学、社会和临床特征。
2011年,DOPPS方案在北京、广州和上海45家机构的1379名患者中实施。将中国的数据与核心DOPPS国家的11054名患者的横断面数据(2009 - 2011年收集)进行比较。在中国DOPPS患者中,采用逻辑回归和线性回归来描述透析频率与患者、治疗特征及生活质量之间的关联。
中国共有26%的患者每周透析两次,而其他DOPPS地区这一比例低于5%。与其他地区(2.12 - 2.27)相比,中国的标准化Kt/V最低(2.01)。女性、透析时间较短、社会经济地位较低、医疗保险覆盖不足以及无糖尿病和高血压与每周两次透析(相对于每周三次透析)相关。每周透析两次的患者治疗时间更长,标准化Kt/V更低,但生活质量评分相似。
每周两次透析在中国很常见,尤其是在透析开始时间较晚、合并症负担较轻且有经济限制的患者中。每周两次和每周三次透析组的生活质量评分没有差异。对临床结局的影响值得进一步研究。